Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SGYP

Synergy Pharmaceuticals (SGYP) Stock Price, News & Analysis

Synergy Pharmaceuticals logo

About Synergy Pharmaceuticals Stock (NASDAQ:SGYP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.01
$0.03
52-Week Range
N/A
Volume
N/A
Average Volume
6.08 million shs
Market Capitalization
$7.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SGYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Synergy Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SGYP Stock News Headlines

Jose Solorio
Could This Be the End of Retirement Worries?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel
Synergy Pharmaceuticals Inc Unit (SGYPU)
Different resistors
Mains cables
See More Headlines

SGYP Stock Analysis - Frequently Asked Questions

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) announced its quarterly earnings data on Thursday, November, 8th. The biopharmaceutical company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.13) by $0.01. The biopharmaceutical company earned $11.11 million during the quarter, compared to analyst estimates of $15.65 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Synergy Pharmaceuticals investors own include Novavax (NVAX), Immunomedics (IMMU), Progenics Pharmaceuticals (PGNX), Westmoreland Coal (WLB), ACADIA Pharmaceuticals (ACAD), Cara Therapeutics (CARA) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
11/08/2018
Today
8/24/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:SGYP
CIK
1347613
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$224.33 million
Net Margins
-332.11%
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-118.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.52
Quick Ratio
0.38

Sales & Book Value

Annual Sales
$16.82 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
248,040,000
Free Float
N/A
Market Cap
$7.44 million
Optionable
Optionable
Beta
4.94
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:SGYP) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners